Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
Reliance Industries Limited (RIL) and the Athletics Federation of India (AFI) have entered into a long-term partnership to enable the holistic growth of athletics in India.
EXAMIANS